Wnt signaling in stem cells and non-small-cell lung cancer

Clinical Lung Cancer

Volumn 7, Issue 1, 2005, Pages 54-60

  He, Biao ^a   Barg, Richard N ^a   You, Liang ^a   Xu, Zhidong ^a   Reguart, Noemi ^a,b   Mikami, Iwao ^a   Batra, Sonny ^a   Rosell, Rafael ^b   Jablons, David M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

APC gene; Carcinogenesis; Disheveled proteins; Hedgehog signaling; catenin

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTINEOPLASTIC AGENT; APC PROTEIN; BETA CATENIN; DISHEVELLED 1; DISHEVELLED 2; GENE PRODUCT; GLYCOGEN SYNTHASE KINASE 3BETA; MONOCLONAL ANTIBODY; PROTEIN CDC42; PROTEIN DVL 3; PROTEIN KINASE C; RAC PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; WNT PROTEIN ANTAGONIST;

ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CELL MUTANT; CELL REGENERATION; DRUG TARGETING; GENE MUTATION; GENE OVEREXPRESSION; GENETIC EPIGENESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; LUNG CANCER; LUNG CARCINOGENESIS; LUNG DEVELOPMENT; LUNG NON SMALL CELL CANCER; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; STEM CELL; TISSUE REGENERATION; TISSUE REPAIR;

EID: 23844481478     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2005.n.022     Document Type: Article

References (136)

1. Preston SL, Alison MR, Forbes SJ, et al. The new stem cell biology: something for everyone. Mol Pathol 2003; 56:86-96.
2. Morrison SJ, Weissman IL. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1994; 1:661-673.
3. Baum CM, Weissman IL, Tsukamoto AS, et al. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A 1992; 89:2804-2808.
4. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science 1988; 241:58-62.
5. Zimmermann S, Voss M, Kaiser S, et al. Lack of telomerase activity in human mesenchymal stem cells. Leukemia 2003; 17:1146-1149.
6. Simonsen JL, Rosada C, Serakinci N, et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 2002; 20:592-596.
7. Otto WR. Lung epithelial stem cells. J Pathol 2002; 197:527-535.
8. Marx J. Cancer research. Mutant stem cells may seed cancer. Science 2003; 301:1308-1310.
9. Park CH, Bergsagel DE, McCulloch EA. Mouse myeloma tumor stem cells: a primary cell culture assay. J Natl Cancer Inst 1971; 46:411-422.
10. Till JE, Me CE. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 1961; 14:213-222.
11. Hope K, Jin L, Dick J. Acute myeloid leukemia originates from hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 2004; 5:738-743.
12. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3:730-737.
13. Smith W, Khuri FR. The care of the lung cancer patient in the 21st century: a new age. Semin Oncol 2004; 31:11-15.
14. Wechsler-Reya R, Scott MP. The developmental biology of brain tumors. Annu Rev Neurosci 2001; 24:385-428.
15. Taipale J, Beachy PA. The Hedgehog and Wnt signalling pathways in cancer. Nature 2001; 411:349-354.
16. Thayer SP, di Magliano MP, Heiser PW, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003; 425:851-856.
17. Berman DM, Karhadkar SS, Maitra A, et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003; 425:846-851.
18. Watkins DN, Berman DM, Burkholder SG, et al. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003; 422:313-317.
19. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004; 432:324-331.
20. Karhadkar SS, Bova GS, Abdallah N, et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004; 431:707-712.
21. Lustig B, Behrens J. The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 2003; 129:199-221.
22. van Es JH, Barker N, Clevers H. You Wnt some, you lose some: oncogenes in the Wnt signaling pathway. Curr Opin Genet Dev 2003; 13:28-33.
23. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14:1837-1851.
24. Akiyama T. Wnt/beta-catenin signaling. Cytokine Growth Factor Rev 2000; 11:273-282.
25. Eastman Q, Grosschedl R. Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol 1999; 11:233-240.
26. Veeman MT, Axelrod JD, Moon RT. A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 2003; 5:367-377.
27. Korinek V, Barker N, Moerer P, et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 1998; 19:379-383.
28. Brennan KR, Brown AM. Wnt proteins in mammary development and cancer. J Mammary Gland Biol Neoplasia 2004; 9:119-131.
29. Pandur P, Lasche M, Eisenberg LM, et al. Wnt-11 activation of non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 2002; 418:636-641.
30. Reya T, Duncan AW, Ailles L, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003; 423:409-414.
31. Morrisey EE. Wnt signaling and pulmonary fibrosis. Am J Pathol 2003; 162:1393-1397.
32. Yamaguchi T, Bradley A, McMahon A, et al. A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development 1999; 126:1211-1223.
33. Weidenfeld J, Shu W, Zhang L, et al. The WNT7b promoter is regulated by TTF-1, GATA6, and Foxa2 in lung epithelium. J Biol Chem 2002; 277:21061-21070.
34. Li C, Xiao J, Hormi K, et al. Wnt5a participates in distal lung morphogenesis. Dev Biol 2002; 248:68-81.
35. Shu W, Jiang YQ, Lu MM, et al. Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development 2002; 129:4831-4842.
36. Bonner AE, Lemon WJ, You M. Gene expression signatures identify novel regulatory pathways during marine lung development: implications for lung tumorigenesis. J Med Genet 2003; 40:408-417.
37. Chilosi M, Poletti V, Zamo A, et al. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 2003; 162:1495-1502.
38. Zhang Y, Kalderon D. Hedgehog acts as a somatic stem cell factor in the Drosophila ovary. Nature 2001; 410:599-604.
39. Machold R, Hayashi S, Rutlin M, et al. Sonic hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches. Neuron 2003; 39:937-950.
40. Lai K, Kaspar BK, Gage FH, et al. Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo. Nat Neurosci 2003; 6:21-27.
41. Pinto D, Gregorieff A, Begthel H, et al. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev 2003; 17:1709-1713.
42. + adult stem cells during muscle regeneration. Cell 2003; 113:841-852.
43. Owens DM, Watt FM. Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev Cancer 2003; 3:444-451.
44. Perez-Losada J, Balmain A. Stem-cell hierarchy in skin cancer. Nat Rev Cancer 2003; 3:434-443.
45. Bhardwaj G, Murdoch B, Wu D, et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol 2001; 2:172-180.
46. Ramalho-Santos M, Melton DA, McMahon AP. Hedgehog signals regulate multiple aspects of gastrointestinal development. Development 2000; 127:2763-2772.
47. Gat U, DasGupta R, Degenstein L, et al. De Novo hair follicle morphogenesis and hair tumors in mice expressing truncated beta-catenin in skin. Cell 1998; 95:605-614.
48. van de Wetering M, Sancho E, Verweij C, et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002; 111:241-250.
49. Shackel NA, McGuinness PH, Abbott CA, et al. Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut 2001; 49:565-576.
50. Surendran K, Simon TC. CNP gene expression is activated by Wnt signaling and correlates with Wnt4 expression during renal injury. Am J Physiol Renal Physiol 2003; 284:F653-F662.
51. Monga SP, Pediaditakis P, Mule K, et al. Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology 2001; 33:1098-1109.
52. Liu BY, McDermott SP, Khwaja SS, et al. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc Natl Acad Sci U S A 2004; 101:4158-4163.
53. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315:1650-1659.
54. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860-867.
55. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000; 103:311-320.
56. (http://www.cancer.org)
57. Morin PJ, Sparks AB, Korinek V, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275:1787-1790.
58. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science 1997; 275:1784-1787.
59. Rhee CS, Sen M, Lu D, et al. Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 2002; 21: 6598-6605.
60. Weeraratna AT, Jiang Y, Hostetter G, et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 2002; 1:279-288.
61. Lu D, Zhao Y, Tawatao R, et al. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2004; 101:3118-3123.
62. Nusse R, Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of host genome. Cell 1982; 31:99-109.
63. Katoh M. Expression and regulation of WNT1 in human cancer: up-regulation of WNT1 by beta-estradiol in MCF-7 cells. Int J Oncol 2003; 22:209-212.
64. Wong SC, Lo SF. Lee KC, et al. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours. J Pathol 2002; 196:145-153.
65. Chen S, Guttridge DC, You Z, et al. Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription. J Cell Biol 2001; 152:87-96.
66. He B, You L, Uematsu K, et al. A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 2004; 6:7-14.
67. Katoh M. Frequent up-regulation of WNT2 in primary gastric cancer and colorectal cancer. Int J Oncol 2001; 19:1003-1007.
68. Yoshida MC, Wada M, Satoh H, et al. Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer. Proc Natl Acad Sci U S A 1988; 85:4861-4864.
69. Roelink H, Wagenaar E, Nusse R. Amplification and proviral activation of several Wnt genes during progression and clonal variation of mouse mammary tumors. Oncogene 1992; 7:487-492.
70. Nessling M, Solinas-Toldo S, Wilgenbus KK, et al. Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes MYCN, MET, WNT2, and ERBB2. Genes Chromosomes Cancer 1998; 23:307-316.
71. Katoh M, Kirikoshi H, Terasaki H, et al. WNT2B2 mRNA, up-regulated in primary gastric cancer, is a positive regulator of the WNT-beta-catenin-TCF signaling pathway. Biochem Biophys Res Commun 2001; 289:1093-1098.
72. Vider BZ, Zimber A, Chastre E, et al. Evidence for the involvement of the Wnt 2 gene in human colorectal cancer. Oncogene 1996; 12:153-158.
73. Holcombe RF, Marsh JL, Waterman M, et al. Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma. Mol Pathol 2002; 55:220-226.
74. Katoh M. Differential regulation of WNT2 and WNT2B expression in human cancer. Int J Mol Med 2001; 8:657-660.
75. Pham K, Milovanovic T, Barr R, et al. Wnt expression in malignant melanoma: pilot study indicating correlation with histopathological features. Mol Pathol 2003; 56:280-285.
76. You L, He B, Xu Z, et al. Inhibition of Wnt-2-mediated signaling induces programmed cell death in non small cell lung cancer cells. Oncogene 2004; 23:6170-6174.
77. Calvo R, West J, Franklin W, et al. Altered HOX and WNT7A expression in human lung cancer. Proc Natl Acad Sci U S A 2000; 97:12776-12781.
78. Winn RA, Marek L, Han SY, et al. Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation. J Biol Chem 2005; 280:19625-19634.
79. Ohira T, Gemmill RM, Ferguson K, et al. WNT7a induces E-cadherin in lung cancer cells. Proc Natl Acad Sci U S A 2003; 100:10429-10434.
80. Kengaku M, Capdevila J, Rodriguez-Esteban C, et al. Distinct WNT pathways regulating AER formation and dorsoventral polarity in the chick limb bud. Science 1998; 280:1274-1277.
81. Moon RT, Brown JD, Torres M. WNTs modulate cell fate and behavior during vertebrate development. Trends Genet 1997; 13:157-162.
82. Saitoh T, Mine T, Katoh M. Frequent up-regulation of WNT5A mRNA in primary gastric cancer. Int J Mol Med 2002; 9:515-519.
83. Liang H, Chen Q, Coles AH, et al. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 2003; 4:349-360.
84. Nakano T, Tani M, Ishibashi Y, et al. Biological properties and gene expression associated with metastatic potential of human osteosarcoma. Clin Exp Metastasis 2003; 20:665-674.
85. Kawano Y, Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 2003; 116:2627-2634.
86. Ko J, Ryu K, Lee Y, et al. Human secreted frizzled-related protein is down-regulated and induces apoptosis in human cervical cancer. Exp Cell Res 2002; 280:280-287.
87. Ugolini F, Charafe-Jauffret E, Bardou VJ, et al. WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene 2001; 20:5810-5817.
88. To KF, Chan MW, Leung WK, et al. Alterations of frizzled (FzE3) and secreted frizzled related protein (hsFRP) expression in gastric cancer. Life Sci 2001; 70:483-489.
89. Suzuki H, Gabrielson E, Chen W, et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002; 31:141-149.
90. Suzuki H, Watkins DN, Jair KW, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004; 36:417-22.
91. Caldwell GM, Jones C, Gensberg K, et al. The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res 2004; 64:883-888.
92. Hsieh JC, Kodjabachian L, Rebbert ML, et al. A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 1999; 398:431-436.
93. Wissmann C, Wild PJ, Kaiser S, et al. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung and bladder cancer. J Pathol 2003; 201:204-212.
94. Mazieres J, He B, You L, et al. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res 2004; 64:4717-4720.
95. Lee AY, He B, You L, et al. Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Oncogene 2004; 23:6672-6676.
96. Fedi P, Bafico, A, Nieto Soria A, et al. Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling. J Biol Chem 1999; 274:19465-19472.
97. Tsuji T, Miyazaki M, Sakaguchi M, et al. A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun 2000; 268:20-24.
98. Nozaki I, Tsuji T, Iijima O, et al. Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer. Int J Oncol 2001; 19:117-121.
99. Tsuji T, Nozaki I, Miyazaki M, et al. Antiproliferative activity of REIC/DKK-3 and its significant down-regulation in non-small-cell lung carcinomas. Biochem Biophys Res Commun 2001; 289:257-263.
100. Kobayashi K, Ouchida M, Tsuji T, et al. Reduced expression of the REIC/DKK-3 gene by promoter-hypermethylation in human tumor cells. Gene 2002; 282:151-158.
101. Zeng L, Fagotto F, Zhang T, et al. The mouse Fused locus encodes Axin, an inhibitor of the Wnt pathway that regulates embryonic axis formation. Cell 1997; 90:181-192.
102. Ponting CP, Phillips C, Davies KE, et al. PDZ domains: targeting signalling molecules to sub-membranous sites. Bioessays 1997; 19:469-479.
103. Ponting CP, Bork P. Pleckstrin's repeat performance: a novel domain in G-protein signaling? Trends Biochem Sci 1996; 21:245-246.
104. Uematsu K, He B, You L, et al. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 2003; 22:7218-7221.
105. Uematsu K, Kanazawa S, You L, et al. Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin. Cancer Res 2003; 63:4547-4551.
106. Wharton KA, Jr. Runnin' with the Dvl: proteins that associate with Dsh/Dvl and their significance to Wnt signal transduction. Dev Biol 2003; 253:1-17.
107. Cooper CA, Bubb VJ, Smithson N, et al. Loss of heterozygosity at 5q21 in non-small cell lung cancer: a frequent event but without evidence of apc mutation. J Pathol 1996; 180:33-37.
108. Horii A, Nakatsuru S, Miyoshi Y, et al. Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res 1992; 52:6696-6698.
109. Furuuchi K, Tada M, Yamada H, et al. Somatic mutations of the APC gene in primary breast cancers. Am J Pathol 2000; 156:1997-2005.
110. Ohgaki H, Kros JM, Okamoto Y, et al. APC mutations are infrequent but present in human lung cancer. Cancer Lett 2004; 207:197-203.
111. Hommura F, Furuuchi K, Yamazaki K, et al. Increased expression of beta-catenin predicts better prognosis in nonsmall cell lung carcinomas. Cancer 2002; 94:752-758.
112. Retera JM, Leers MP, Sulzer MA, et al. The expression of beta-catenin in non-small-cell lung cancer: a clinicopathological study. J Clin Pathol 1998; 51:891-894.
113. Kase S, Sugio K, Yamazaki K, et al. Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res 2000; 6:4789-4796.
114. Barker N, Morin PJ, Clevers H. The Yin-Yang of TCF/beta-catenin signaling. Adv Cancer Res 2000; 77:1-24.
115. Sunaga N, Kohno T, Kolligs FT, et al. Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma. Genes Chromosomes Cancer 2001; 30:316-321.
116. Shigemitsu K, Sekido Y, Usami N, et al. Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion. Oncogene 2001; 20:4249-4257.
117. Ueda M, Gemmill RM, West J, et al. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer 2001; 85:64-68.
118. Nakatani Y, Masudo K, Miyagi Y, et al. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules. Mod Pathol 2002; 15:617-624.
119. Habas R, Kato Y, He X. Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires novel Formin homology protein Daam1. Cell 2001; 107:843-854.
120. + signaling pathway. Dev Biol 2002; 244:342-357.
121. Penzo-Mendez A, Umbhauer M, Djiane A, et al. Activation of Gbetagamma signaling downstream of Wnt-11/Xfz7 regulates Cdc42 activity during Xenopus gastrulation. Dev Biol 2003; 257:302-314.
122. Hordijk PL, ten Klooster JP, van der Kammen RA, et al. Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science 1997; 278:1464-1466.
123. Soon LL, Yie TA, Shvarts A, et al. Overexpression of WISP-1 down-regulated motility and invasion of lung cancer cells through inhibition of Rac activation. J Biol Chem 2003; 278:11465-11470.
124. Tao W, Pennica D, Xu L, et al. Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1. Genes Dev 2001; 15:1796-1807.
125. Habas R, Dawid IB, He X. Coactivation of Rac and Rho by Wnt/Frizzled signaling is required for vertebrate gastrulation. Genes Dev 2003; 17:295-309.
126. Allal C, Favre G, Couderc B, et al. RhoA prenylation is required for promotion of cell growth and transformation and cytoskeleton organization but not for induction of serum response element transcription. J Biol Chem 2000; 275:31001-31008.
127. Mazieres J, Antonia T, Daste G, et al. Loss of RhoB expression in human lung cancer progression. Clin Cancer Res 2004; 10:2742-2750.
128. Ikoma T, Takahashi T, Nagano S, et al. A definitive role of RhoC in metastasis of orthotopic lung cancer in mice. Clin Cancer Res 2004; 10:1192-1200.
129. del Peso L, Hernandez-Alcoceba R, Embade N, et al. Rho proteins induce metastatic properties in vivo. Oncogene 1997; 15:3047-3057.
130. Yao R, Wang Y, Lubet RA, et al. Differentially expressed genes associated with mouse lung tumor progression. Oncogene 2002; 21:5814-5821.
131. Malliri A, Collard JG. Role of Rho-family proteins in cell adhesion and cancer. Curr Opin Cell Biol 2003; 15:583-589.
132. Boutros M, Paricio N, Strutt DI, et al. Dishevelled activates JNK and discriminates between JNK pathways in planar polarity and wingless signaling. Cell 1998; 94:109-118.
133. Moriguchi T, Kawachi K, Kamakura S, et al. Distinct domains of mouse dishevelled are responsible for the c-Jun N-terminal kinase/stress-activated protein kinase activation and the axis formation in vertebrates. J Biol Chem 1999; 274:30957-30962.
134. You L, He B, Uematsu K, et al. Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells. Cancer Res 2004; 64:3474-3478.
135. He B, Lee AY, Dadfarmay S, et al. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells. Cancer Res 2005; 65:743-748.
136. Lee AY, He B, You L, et al. Dickkopf-1 antagonizes Wnt signaling independent of β-catenin in human mesothelioma. Biochem Biophys Res Commun 2004; 323:1246-1250.